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ABSTRACT: The HR-MAS is an ideal technique for the investigation of intact tissue
specimens (10–50 mg) and permits the obtainment of spectra with a resolution comparable
to that observed in solution in a time that does not exceed a half of an hour for a routine
analysis. The potentialities of HR-MAS NMR spectroscopy in the identification of the
metabolites characterizing the healthy gastric mucosa are here presented. The direct
inspection of the 1D 1H NMR spectra enables only few metabolites to be confidently
assigned, and the use of selected 2D experiments strongly amplify the analytical effective-
ness of the technique. © 2006 Wiley Periodicals, Inc. Concepts Magn Reson Part A 28A:
430–443, 2006
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INTRODUCTION
NMR is a powerful tool for the structure determina-
tion of biomolecules and natural compounds, for the
study of tissue extracts or intact tissues, and for ob-
taining detailed three-dimensional maps of the human
body and organs. In the field of biomedicine, the two
areas of NMR are represented by magnetic resonance
imaging (MRI) and by the multibranched magnetic
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resonance spectroscopy (MRS), where MRS is the
acronym used in place of NMR. MRI uses the strong
signals from water protons to provide detailed ana-
tomical maps and has proven to be an indispensable
tool for researchers and clinicians, but its specificity
in defining the pathology is limited to only some
diseases. In vivo MRS provides the spectra of living
tissues, directly correlated to their chemical composi-
tion but, due to the low mobility of the majority of
tissue components, which sensibly broaden the signal
line widths, and to the signals overlapping, only few
metabolites can be distinguished and assigned unam-
biguously. The in vivo MRS (1–3) is considered a
radiological tool able to help the imaging methods in
the evaluation of several human pathologies, includ-
ing cancer. Nevertheless, in vivo MRS can be used
when the molecular markers of tissues are well estab-
lished by means of a detailed biochemical picture,
which can be derived from the spectroscopic analysis
of in vitro extracts (aqueous or lipidic) of tissues or
cells and from ex vivo biopsy samples using high-
resolution magic angle spinning (HR-MAS) NMR
technique.
HR-MAS NMR can be considered a hybrid tech-
nique between solid-state NMR and classical solution
state NMR. It uses, similar to solid-state NMR, the
magic angle spinning (MAS) (4 ), but it retains the
classical solution NMR experiments. Similar to solu-
tion NMR, HR-MAS NMR involves direct polariza-
tion transfer and not cross-polarization transfer (CP-
MAS) (5 ) between 1H and heteronuclei (13C or 15N),
thus distinguishing it from CP-MAS experiments on
true solids.
HR-MAS uses dedicated probeheads capable of
studying the samples in rapid rotation (3  15 kHz)
around an axis 54.7° (“magic angle”) tilted with re-
spect to that of the static magnetic field (B0) (Fig. 1).
These probeheads drastically reduce contributions
from dipolar couplings, chemical shift anisotropy, and
susceptibility distortions, providing high-resolution
spectra from semisolid samples, such as tissues. The
quality of the obtained spectra is comparable to that
obtained from aqueous extracts, and the acquisition
techniques used are those employed in high-resolution
NMR in solution. The advantage is that of carrying
out the measurements on intact tissue specimens,
without any pretreatment enabling the extraction step
to be omitted, and aqueous and lipid fractions to be
detected simultaneously, enhancing the possibility of
identifying biochemical markers with diagnostic and
prognostic value. After the first applications of HR-
MAS NMR on human tissue specimens (6, 7 ), some
articles on ex vivo HR-MAS spectroscopic studies on
different organ tissues have appeared (8–10) .
Here we present the application of HR-MAS NMR
to the ex vivo characterization of healthy gastric mu-
cosa tissues. These findings will form a rational basis
for in vivo MRS in the evaluation of neoplasms of
human gastric mucosa cancer, which is a leading
cause of cancer-related deaths in many parts of the
world (11, 12).
SAMPLE SELECTION AND TREATMENT
The samples chosen should be representative of the
gastric mucosa, and, in particular, the biopsies should
be obtained on healthy tissues that do not present
visible macroscopic alterations. The tissues are to be
considered healthy only when the histologic exami-
nation confirms the macroscopic finding, mainly
when these studies are undertaken for the first time.
The original samples are to be put rapidly in liquid
nitrogen and stored at 85°C until NMR analyses.
The samples can be preserved up to 3 months without
observing changes in the spectra, and the measure-
ments should be taken within this period. Immediately
before NMR analysis, the tissue sample is cut to have
suitable dimensions and flushed with D2O to elimi-
nate residual blood (thus reducing the iron content,
with the aim to improve the homogeneity, and in turn
the water suppression) and to add deuterium as
Figure 1 Schematic representation of HR-MAS probe (left); HR-MAS rotor (right).
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nucleus for the lock system. The specimens are then
transferred into the MAS zirconia rotors (4 mm OD)
that are available in different capacities (12, 50, 90
L), and are chosen in relation to the sample amount.
A Teflon perforated insert is used to restrict the vol-
ume, to eliminate bubbles, and to improve the homo-
geneity of the sample. The insert is closed by a screw,
then the rotor by a cap—the star shape of which
provides the driving for the rotor (see Fig. 1). The
rotor is then placed in the stator and the sample spun
at 4000 Hz. The rotation rate is selected to have the
spinning sidebands out of the region of interest (10
ppm). The temperature of the sample is maintained at
278 K to limit sample degradation. Sample and in-
strument preparation takes about 20 min.
HR-MAS NMR MEASUREMENTS
One-Dimensional NMR Spectra
The NMR experiments in obtaining HR-MAS spectra
of tissues are the same as those used in solution. A
generally employed basic set of experiments is
formed by:
1. The 1D 1H NMR experiment with suppression
of the residual HDO/H2O generates a spectrum
containing signals from metabolites, macromol-
ecules, and lipids. It is necessary to suppress
water signal because its high intensity can ob-
scure the resonances of the other components.
Among several approaches that can be adopted
(13), the presaturation one is that preferred by
us. It consists in the irradiation of the HDO/
H2O signal with a weak radiofrequency field B1
(50 Hz) for some seconds prior to the acquisi-
tion of the 1H spectrum. This method is more
selective than others, but it is not recommended
when peaks from protons involved in chemical
exchange processes with water are studied, be-
cause their signals are reduced or lost.
2. The water-suppressed spin-echo experiment
(Carr-Purcell-Meiboom-Gill, CPMG) (14 ) act-
ing as a T2 filter cuts off signals from macro-
molecules and lipids, leaving only signals from
small metabolites. The experiment employs the
pulse sequence:
d1-90°--180°-n-AQ
where d1 is the relaxation delay, 	 the echo
time, and AQ the acquisition time. The 90°
pulse creates a transverse magnetization that
decays during the spin-echo period (	-180°- 	)n.
Macromolecules having short T2 [T2 can be
estimated by the half-height line width lw1/2 by
the equation lw1/2
1/(T2)] should be com-
pletely relaxed and filtered out. The echo time
2n	 can be varied in relation to the T2 of the
macromolecules. The water suppression irradi-
ation is used during d1 and is conventionally set
to 1.5 ms.
3. The gradient-based stimulated-echo pulse se-
quence (with bipolar-gradient pulse pairs and
longitudinal-eddy current delay, LED) (15 )
generates a spectrum in which signals coming
from slowly diffusing molecules are retained at
expenses of those from low molecular weight
metabolites, which are, in turn, reduced. The
experiment employs the following pulse se-
quence:
d1-90-g1--180-g2--90-g3--90-g1-
-180-g2--90-g4-d21-90-AQ
where g2 
 g1, the diffusion time d20 

90--180--90- and d21 is the eddy-current
time. The correct selection of d20 and the gra-
dient strength permits to filter out signals from
fast moving small molecules and to retain only
macromolecules.
These last two experiments exploit the different
relaxation and diffusion properties of small metabo-
lites with respect to macromolecules and lipids. The
accurate choice of the spin-spin relaxation delay 2n	
and of parameters influencing diffusion (gradient-field
pulse duration , gradient strength, and diffusion time
) enables two complementary sets of signals, corre-
sponding to narrow and broad components, to be
isolated. The acquisition of a diagnostic set of 1D
HR-MAS spectra requires about 30 min, but the cor-
rect and complete attribution of the whole resonances
is based on 2D techniques, which require much more
time.
Two-Dimensional NMR Spectra
2D NMR spectra can be a valuable aid in elucidating
complex NMR spectra, permitting identification of
unknown compounds mainly by analyzing their spin-
spin correlations through chemical bonds. Among the
plethora of 2D experiments found in the literature, the
most effective, and thus most commonly employed,
for the identifications of metabolites in mixtures are
COrrelation SpectroscopY (COSY) (16 ), TOtal Cor-
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relation SpectroscopY (TOCSY) (17, 18 ), and Het-
eronuclear Single Quantum Coherence (HSQC) (19)
or Heteronuclear Multiple Quantum Coherence
(HMQC) (20) experiments.
1. COSY experiments, based on the transfer of
spin information between coupled spins, afford
spectra as 2D plots in which signals correspond-
ing to the 1D spectrum are on the diagonal,
whereas off-diagonal peaks, called cross-peaks,
are found between pairs of coupled spins. These
correlations are usually due to connections
through two and three bonds, but long-range
connectivities can sometimes be observed.
2. TOCSY experiments enable all the components
of a spin system to be detected (at least in
principle). The core of these experiments is a
spin-lock time, which allows transfer of infor-
mation from one spin to another belonging to
the same coupling network, even if these spins
are separated by many bonds. The mixing time
must be held long enough (from 60 to 140 ms)
to complete the transfer process to all the spins.
The TOCSY spectra permit the identification of
1H,1H connectivities up to five or six bonds.
3. Inverse-detection experiments HMQC and
HSQC enable pairs of protons and carbons di-
rectly bonded to be found. These are basically
heteronuclear COSY experiments that rely on
the acquisition of the more receptive nucleus
(i.e., the proton), whereas the chemical shift of
the heteronucleus is found in the second dimen-
sion. The knowledge of the carbon chemical
shift associated to the proton one represents a
key step in the identification of a metabolite.
To acquire a complete set of good-quality 2D
spectra, 15–20 hours of acquisition are required.
EXPERIMENTAL DETAILS
Proton HR-MAS spectra were recorded with a Bruker
Avance400 spectrometer equipped with a 1H/13C HR-
MAS probe (operating at 400.13 and 100.61 MHz,
respectively) and with a Bruker Cooling Unit (BCU)
for temperature control. Samples were spun at 4000
Hz, and three different types of 1D proton spectra
were acquired using sequences implemented in the
Bruker software: (i) a standard sequence with 1.5 s
water presaturation during relaxation delay, 8 kHz
spectral width, 32k data points, 32–64 scans, (ii) a
water-suppressed spin-echo CPMG sequence with
1.5 s water presaturation during relaxation delay, 1 ms
echo time (	) and 360 ms total spin-spin relaxation
delay (2n	), 8 kHz spectral width, 32k data points,
256 scans, and (iii) a sequence for diffusion measure-
ments based on stimulated echo and bipolar-gradient
pulses with big delta 200 ms, eddy current delay Te 5
ms, little delta 2*2 ms, sine-shaped gradient with 32
G/cm followed by a 200 s delay for gradient recov-
ery, 8 kHz spectral width, 8k data points, and 256
scans. Two-dimensional COSY spectra were acquired
using a standard pulse sequence and 0.5 s water
presaturation during relaxation delay, 8 kHz spectral
width, 4k data points, 32 scans per increment, and 256
increments. Two-dimensional TOCSY spectra were
acquired using a standard pulse sequence and 1 s
water presaturation during relaxation delay, 100 ms
mixing (spin-lock) time, 4 kHz spectral width, 4k data
points, 32 scans per increment, and 128 increments.
Two-dimensional HSQC spectra were acquired using
a standard pulse sequence echo-antiecho phase sensi-
tive and 0.5 s relaxation delay, 1.725 ms evolution
time, 4 kHz spectral width in f2, 4k data points, 128
scans per increment, 17 kHz spectral width in f1, and
256 increments.
It is not necessary to add a reference standard for
the chemical shift scale, such as TSP (trimethylsilyl-
propansulfonate), but our suggestion is to use a well-
known resonance as internal standard, such as H-1 of
-glucose (Glc) (a doublet at 5.24 ppm, J 
 3.8 Hz)
or the methyl of alanine (Ala) or lactate (Lac) (dou-
blets at 1.48 ppm, J 
 7.2 Hz, and 1.33 ppm, J 
 6.9
Hz, respectively). Attention should be paid when us-
ing the signal of HDO to calibrate the chemical shift
scale, for it is highly temperature dependent.
TEMPERATURE EFFECTS
All samples were studied under temperature control
conditions, at 278 K. This was necessary to slow
down tissue degradation processes, which are found
to be more evident at room temperature. Two sets of
representative 1D proton spectra obtained at 300 and
278 K at different times (0 and 18–21 h) from two
samples of normal gastric mucosa are displayed in
Fig. 2. They were all acquired using a water-presatu-
ration sequence with composite pulse and are infor-
mative of small and large metabolites present in the
tissue. The two spectra at t 
 0 (a and c) are similar,
except for a different intensity of the signal at 3.72
ppm due to polyethylene glycol (PEG), used as an
excipient in pharmaceutical preparations, and for a
slightly better spectral resolution in the case of c).
After almost 1 day, an increase in the signals of small
metabolites, more evident at the higher work temper-
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ature (see b versus d), can be observed. These spectral
changes are attributable to the increased mobility of
some metabolites and to the partial disruption of sub-
cellular structures, probably due to temperature and
spinning. Degradation symptoms only slightly affect
the samples in the first hour of analysis and, in the
view of future applications of HR-MAS with diagnos-
tic purposes, they do not have to be overemphasized.
Nevertheless, these findings prompted us to work at
278 K, especially to safely acquire 2D spectra, which
are more time-consuming than the 1D ones.
METABOLITES ANALYSIS
A pool of 10 biopsies from healthy gastric mucosa
were studied. Typically, three 1D experiments were
recorded for each sample (Fig. 3). The water-presatu-
rated 1D spectrum (see Fig. 3a) displays the contri-
bution of the resonances deriving from small metab-
olites with long spin-spin relaxation times T2, hence
narrow bandwidth, that can be readily distinguished
from that of macromolecules and lipids with short
Figure 2 1D water-presaturated 1H NMR spectra of healthy gastric mucosa: (a) sample 1 at 300
K, t 
 0 h; (b) sample 1 at 300 K, t 
 21 h; (c) sample 2 at 278 K, t 
 0 h; (d) sample 2 at 278
K, t 
 18 h.
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(but not so short to be NMR invisible) T2, hence large
bandwidth. The CPMG spin-echo sequence elimi-
nates the contribution of the broad resonances and
retains only narrow signals from small molecules (see
Fig. 3b). The diffusion-edited spectrum permits to
observe components with low diffusion rates and
large line width, mainly deriving from lipids, in the
present case phospholipids, and mobile peptidic resi-
dues (see Fig. 3c).
It is apparent, especially to a trained eye, that some
metabolites [e.g., doublets at 1.33 and 1.48 ppm for
Lac and Ala, respectively; triplets at 2.36 and 3.42
ppm for glutamate (Glu) and taurine (Tau), respec-
tively; singlets at 3.04, 3.20, 3.22, 3.56 ppm for cre-
atine (Cr), choline (Cho), glycerophosphorylcho-
line  phosphorylcholine (GPC  PC) and glycine
(Gly), respectively; multiplets at 4.06, 3.63 and 3.53
for myo-inositol (Myo)] can be readily assigned by
direct inspection of the 1D 1H NMR spectra, mainly
the spin-echo one, and by comparison with literature
data, but a complete and unambiguous assignment
requires the acquisition of selected 2D experiments.
Figure 3 1D proton NMR spectra of healthy gastric mucosa obtained with (a) water-presaturation
pulse sequence with composite pulse; (b) CPMG sequence with total spin-echo time 2n	 
 360 ms;
(c) diffusion-edited spectrum obtained with 
 200 ms,  
 4 ms and gradient strength of 32 G/cm.
The metabolites are identified according to Table 1.
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We found that COSY, TOCSY, and HSQC spectra are
the most effective in this respect (whereas J-resolved
experiments are less suitable). They all are highly
informative for the identification of hidden reso-
nances. In particular, the HSQC experiment makes
possible a more reliable assignment of signals, by
comparison of 1H and 13C data with those of the
literature, and the distinction among signals from dif-
ferent molecules having similar proton chemical
shifts but diverse 13C signals. The COSY and TOCSY
spectra (Figs. 4 and 5) allow us to detect a pool of
metabolites, especially osmolites and free amino ac-
ids. The COSY spectra are particularly useful for the
distinction of Lac and threonine (Thr), whose dou-
blets at 1.33 ppm overlap, and for the detection of
-hydrogens of several amino acids (circled in Fig. 4).
They also allow us to distinguish GPC from PC,
whose N(CH3)3 signals are usually unresolved, and
to detect phosphorylethanolamine (PE), whose signals
are found in a crowded region and often hidden under
those of other metabolites (squared in Fig. 4). In all
the examined samples except one, two unknown cou-
pled signals (a triplet at 1.37 and a quartet at 3.37
ppm) were detected in the COSY spectra. The assign-
ment of these signals is discussed elsewhere.
Some metabolites, such as lysine (Lys) and argi-
nine (Arg) (circled in Fig. 5), Myo, and -Glc are
better differentiated in TOCSY spectra. More inter-
estingly, some signals due to -CH of bonded amino
acids (mainly Ala and Thr) are detected in the region
of the 2D spectrum close to the correlations of Lac
and Thr (squared in Fig. 5), and only low correlations
are found for bonded valine (Val). These findings
confirm the presence of mobile peptidic residues that
is apparent from the examination of the diffusion-
edited spectra (see Fig. 3c). The amino acids involved
in the peptidic chains are mainly those carrying ali-
phatic or substituted aliphatic chains, being the aro-
matic region of the proton spectra almost empty.
Some weak correlations attributable to the protons
belonging to fatty acid chains are sometimes detected
through both 2D experiments. Nevertheless, those
due to glycerol protons in triglycerides, at 5.26, 4.30,
and 4.10 ppm, are evident only in one COSY spec-
trum (21).
Further progresses toward the identification of me-
tabolites can be done exploiting the 13C chemical shift
dispersion in the second dimension of HSQC experi-
ments. A region of interest is usually that correspond-
ing to the N(CH3)3 of choline-containing com-
pounds (ChoCC), Tau, Arg, Myo, and PE, which
contribute all to the 3.2 ppm signal in the proton
spectra. These molecules can readily be distinguished
in HSQC spectra (Fig. 6) due to the large differences
in their 13C chemical shifts (circled in Fig. 6) and also
to their multiplicity (CH3 vs. CH2), if edited se-
quences are employed (22). Some problems are en-
countered in the interpretation of the region between
Figure 4 COSY NMR spectrum of healthy gastric mucosa. The identified metabolites are labeled
according to Table 1.
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3.6 and 4.0 ppm, for the presence of overlapped
correlations around 62 ppm, presumably due to glyc-
erols and CH2OH of Glc. All sample spectra show
also a more or less strong resonance at 3.72 (s) ppm
due to PEG, as confirmed by the 13C resonance at 70.3
ppm, used as an excipient in pharmaceuticals.
The 13C chemical shifts dispersion is also useful
for the assignment of the signals of aliphatic amino
acids [isoleucine (Ile), Val, leucine (Leu)] (Fig. 7).
Figure 6 Partial 1H,13C-HSQC spectrum of healthy gas-
tric mucosa. The identified metabolites are labeled accord-
ing to Table 1.
Figure 7 Partial 1H,13C-HSQC spectrum of healthy gas-
tric mucosa. The identified metabolites are labeled accord-
ing to Table 1.
Figure 5 TOCSY NMR spectrum of healthy gastric mucosa. The identified metabolites are labeled
according to Table 1.
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The observed peaks seem to be principally related to
the narrow components appearing in the CPMG spec-
trum (Fig. 3b), with the exception of signals due to
N-acetyl (N-Ac) groups (probably arising from sialic
acid present in glycoproteins or from oligopeptide
components), which are instead evidenced in the dif-
fusion-edited spectrum (see Fig. 3c).
The accurate inspection of COSY, TOCSY, and
HSQC spectra allows us to find signals not directly
attributable to metabolites. Besides signals from PEG
already mentioned, the assignment of other two un-
known signals (a triplet at 1.37 and a quartet at 3.37
ppm), detected in the COSY and TOCSY spectra, was
rather intriguing. The chemical shift of their directly
bonded carbons in the HSQC spectrum is 9.2 and 50.7
ppm, respectively. These H,C chemical shifts are
compatible with those of a molecule containing an
ethyl group bonded to a positively charged nitrogen
and were assigned to the ethyl group of lidocaine
chlorohydrate, which is used as anesthetic prior to
endoscopy. The comparison of the CPMG spectrum
of healthy stomach with that of an authentic sample
allows us to assign to lidocaine chlorohydrate also
another unidentified singlet, at 2.20 ppm (carbon at
17.8 ppm), and a multiplet, at 7.28  7.16 ppm, due
to the methyls bonded to phenyl ring and to the
aromatic protons, respectively. Only the signal com-
ing from the CH2 bridging the N and to the amidic
carbonyl, expected as a singlet at 4.33 ppm (carbon at
53.7 ppm), was not distinguished, probably because it
is obscured by the OCH2 signal of GPC. Eventually,
a correlation detected in COSY and TOCSY spectra,
between protons at 5.08 and 2.03 ppm, can be attrib-
uted to another excipient (i.e., cetylpyridinium)
present together with PEG in the lidocaine solution.
The signal at 5.08 ppm can be directly observed in the
water-presaturated and in the diffusion-edited spectra,
whereas, unlike lidocaine, it is absent in the CPMG
spectra. The application of the whole experiments to
samples of normal human gastric mucosa permitted
the complete and unambiguous identification of the
metabolic pattern typical of this tissue (Table 1).
Further remarks on the relative contents of some
metabolites in healthy gastric mucosa can be done.
Regarding the ChoCC, the 1H NMR spectra evidence
that the PC content is similar or higher than that of
GPC, whereas Cho is present in smaller amount with
respect to its phosphorylated analogues in all the
examined samples. The mean ChoCC/Cho ratio, de-
rived from the integrated areas of N(CH3)3 in
CPMG experiments, is 5  2 (standard deviation).
The ratio ChoCC/Cr (derived from the integrated ar-
eas of the N(CH3)3 signal of ChoCC and the NCH3
signal of Cr) and the ratio ChoCC/Tau (derived from
the integrated areas of the N(CH3)3 signal of ChoCC
and the NCH2 signal of tau) are found around 16  4
and 7  1, respectively.
At the present, the use of in vivo MR spectroscopy
in the study of gastric mucosa is not feasible because
of the difficulties coping with gastric wall move-
ments. However, the findings reported here should
provide the rational bases for the interpretation of the
in vivo MR spectra and its use for diagnostic pur-
poses, in the view of future in vivo methodology
developments. Some peculiarities of ex vivo and in
vivo MR spectra are to be considered before attempt-
ing a direct comparison. The in vivo 1H MR spectra of
human tissues are acquired using spin-echo sequences
(PRESS or STEAM) at two different echo times (TE
38 and 144 ms). The signal-to-noise ratio is higher
and the spectra display more signals when the shorter
TE is used. The spectra obtained in vivo at the longer
TE display fewer resonances due to the more marked
reduction of the signals of macromolecules and lipids
with respect to those of small metabolites. Whatever
the experiment employed, the in vivo spectra always
show signals broader than those present in the ex vivo
ones. To compare the two types of experiments, it is
necessary to apply to ex vivo spectra a line broaden-
ing (5–20 Hz) function, generating signal bandwidths
similar to those found in in vivo ones. The in vivo
spectra obtained at TE 38 and 144 ms should be
compared with the standard 1D and the CPMG spec-
tra, respectively. Eventually, MRS users should be
aware that the in vivo signals at 3.03 ppm receives
contributions not only from Cr but also from bonded
Lys, whereas that generally attributed to ChoCC, at
3.23 ppm, receives contributions also from Tau, Arg,
Myo, Glc, and PE.
CONCLUSIONS
We have shown that HR-MAS is an ideal method for
the analysis of intact tissue specimens, allowing spec-
tra to be obtained with a resolution comparable to that
observed in solution. It requires only small amounts
of tissue (10–50 mg); routine analysis does not ex-
ceed a half of an hour; and it enables small and large
metabolites to be detected simultaneously.
The application of 1H and 13C HR-MAS NMR
allowed us to fully characterize the molecular com-
position of healthy gastric mucosa. The use of suitable
1D and 2D experiments allowed us to identify the
NMR signals from more than 50 species. Among
them only a few can be confidently assigned by direct
inspection of the 1D 1H NMR spectra, whereas
2D COSY, TOCSY, and HSQC strongly amplify the
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Table 1 List of 1H and 13C Chemical Shift (, ppm) of Metabolites and Exogenous Molecules Found in HR-
MAS Spectra of Healthy Gastric Mucosaa,b
Entry Metabolite  1H  13C
1 Fatty acids 0.89 14.13–14.17 CH3
1.31 29.4–32.2 (CH2)n
1.59–1.60 25.2 CH2CCAO
2.02 27.8 CH2CA
2.24 34.2 CH2CAO
2.78 26.2 ACCH2CA
5.30–5.32 130.2; 128.4 CHACH
2 Isoleucine 0.94 (t) 11.7 -CH3
1.02 (d) 15.5 -CH3
1.29, 1.48 25.1 -CH2
1.97 -CH
3.69 -CH
3 Leucine 0.95 (d) 21.5 -CH3
0.97 (d) 22.8 -CH3
1.70 24.8 -CH
1.72 40.4 -CH2
3.74 -CH
4 Valine 0.99 (d) 17.3 -CH3
1.04 (d) 18.7 -CH3
2.25 -CH
3.61 d -CH
5 Threonine 1.33 (d) 20.3 -CH3
4.26 66.6 -CH
3.60 61.2 -CH
6 Lactate 1.33 (d) 20.3 CH3
4.11 69.1 CH
7 Lidocaine chlorohydrate 1.37 (t) 9.2 CH3
3.37 (q) 50.6 CH2
2.20 (s) 17.8 2,6-CH3
8 -Alanine 2.56 32.1 CH2
3.18 40.0 CH2
9 Alanine 1.48 (d) 16.8 -CH3
3.78 51.1 -CH
10 Lysine 3.02 (t) 39.9 ε-CH2
1.71 27.1 -CH2
1.48 22.6 -CH2
1.91 30.6 -CH2
3.79 c -CH
11 Arginine 3.23 41.3 -CH2
1.69 -CH2
1.92 28.1 -CH2
3.78 c -CH
12 Glutamate 2.36 (t) 34.0 -CH2
2.06, 2.14 27.9 -CH2
3.77 c -CH
13 Glutamine 2.44 (td) 31.5 -CH2
2.14 27.2 -CH2
3.78 c -CH
14 Proline 3.43, 3.34 -CH2
2.01 -CH2
2.34, 2.07 -CH2
4.12 -CH
(continued)
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Table 1 (Continued)
Entry Metabolite  1H  13C
15 Methionine 2.13 (s) 14.9 SCH3
2.62 -CH2
2.16 -CH2
3.87 -CH
16 Aspartic acid 2.68, 2.82 37.2 -CH2
3.90 -CH
17 Asparagine 2.85, 2.96 26.3 -CH2
4.01 -CH
18 Creatine 3.04 (s) 37.5 NCH3
3.92 (s) 54.5 CH2
19 Tyrosine 3.06, 3.20 -CH2
3.93 56.7 -CH
6.89 116.5 Hortho
7.23 131.5 Hmeta
20 Phenylalanine 3.11, 3.28 -CH2
3.99 -CH
7.34 130.1 Hortho
7.43 129.6 Hmeta
7.37 Hpara
21 Ethanolamine 3.15 (t) CH2
3.82 (t) CH2
22 Phosphorylethanolamine 3.23 41.1 CH2
4.00 61.1 CH2
23 Glycerophosphorylethanolamine 3.30 CH2
4.10 CH2
24 Free choline 3.20 54.6 N(CH3)3
3.53 68.2 NCH2
4.08 56.5 OCH2
25 Glycerophosphorylcholine 3.22 54.7 N(CH3)3
3.68 NCH2
4.33 OCH2
26 Phosphorylcholine 3.22 54.7 N(CH3)3
3.61 67.3 NCH2
4.22 59.0 OCH2
27 -Glucose 4.67 (d) 96.6 1-CH
3.26 74.8 2-CH
3.49 76.8 3-CH
3.40 69.9 4-CH
3.47 76.8 5-CH
e e 6-CH2
28 Taurine 3.26 (t) 48.1 SCH2
3.42 (t) 35.9 NCH2
29 Myoinositol 3.53 (dd) 71.8 1,3-CH
4.06 (t) 72.9 2-CH
3.63 (t) 73.1 4,6-CH
3.29(t) 75.0 5-CH
30 Scyllo-inositol 3.35 (s) 73.9 CH
31 -Glucose 5.24 (d) 1-CH
3.54 72.5 2-CH
3.73 73.8 3-CH
3.42 70.7 4-CH
e e 6-CH2
32 Glycine 3.56 42.3 CH2
33 PEG 3.72 69.9
34 Glycerol (in lipids) 4.10, 4.30 1,3-CH2
5.26 2-CH
(continued)
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Table 1 (Continued)
Entry Metabolite  1H  13C
35 Glycerol 3.56, 3.65 63.3 1-CH2
3.81 72.7 2-CH
36 Bonded glycerols 3.95–3.70 61.3 1,3-CH2
37 UDP 5.92 1-CHrib
4.35 2-CHrib
5.90 (d) 5-CHur
7.89 (d) 6-CHur
38 Uracil 5.80 (d) 5-CHur
7.54 (d) 6-CHur
39 UMP 5.98 1-CHrib
4.37 2-CHrib
5.97 (d) 5-CHur
8.11 (d) 6-CHur
40 Formiate 8.48
41 Adenosine 8.36 (s)
8.23 (s)
42 Acetate 1.92 24.8 CH3CAO
43 Hypotaurine 2.65 (t) 38.7 SCH2
3.35 (t) 41.2 NCH2
44 Tryptophane 7.73
7.19
7.29
7.52
45 Glc-1-X 5.40 100.2
3.61
46 Glutathione 4.57 56.2 -CH-Cys
2.96 26.3 -CH2-Cys
3.80 -CH-Glu
2.16 -CH2-Glu
2.55 -CH2-Glu
3.77 44.0 CH2-Gly
8.57 NH-Cys
8.36 NH-Gly
47 OH-butyrate 1.18 CH3
4.14
48 Histidine 7.78 (s) 2-CH
7.05 (s) 4-CH
49 Ascorbate 4.52 (d) 4-CH
4.01 5-CH
50 Unknown 1.63 23.5
51 Unknown 2.44
3.44
52 Bonded Thr 1.22 16.2 -CH3
4.24 -CH
4.31 -CH
53 Bonded Ala 1.41 17.1 -CH3
4.32 -CH
54 Bonded Val 0.93 23.0 -CH3
2.08 -CH
4.11 -CH
55 Cetylpyridinium 5.08 NCH2
2.03 -CH2
a 1H chemical shift are referred to alanine doublet at 1.48 ppm.
b 13C chemical shift are referred to alanine at 16.8 ppm.
c C probably contributes to the 3.77, 55.1 ppm cross-peak.
d C probably contributes to the 3.61, 61.1 ppm cross-peak.
e Contribute to the broad correlation between CH2 protons in the region 3.9  3.6 ppm and carbons around 62 ppm in HSQC spectra.
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analytical effectiveness of the technique. The effec-
tiveness of ex vivo 1H HR-MAS NMR in giving an
accurate description of the metabolic pattern of the
examined tissues enhances notably if we consider that
it can provide useful information for the interpretation
of in vivo MRS measurements. The two types of
spectra can be compared directly when the differences
due to echo times and line width are taken into ac-
count. HR-MAS actually gives the molecular bases
for the interpretation of the in vivo spectra.
Moreover, this method is well suited to provide
complementary information to histopathology. What
probably still lacks for the use of HR-MAS with
diagnostic purposes are larger evaluation studies
aimed at the statistical validation of the 1H profiles for
healthy and unhealthy tissues. The first tests per-
formed in our laboratories show that the NMR profile
of gastric neoplastic mucosa is completely different
from that of the healthy one (Fig. 8), making us
foresee a strong diagnostic impact of in vivo, when
implemented, and ex vivo NMR in this field.
The adenocarcinoma proton spectrum is character-
ized by predominant signals due to triglycerides, as
confirmed by the presence of signals due to glycerol
(5.26, 4.30, and 4.10 ppm) and to long fatty acid
chains (saturated and unsaturated). Otherwise, the
healthy mucosa spectrum indicates that triglycerides
are present in low amounts.
Eventually, we have here reported that signals
from exogenous molecules, such as lidocaine, PEG,
and cetylpyridinium, have been detected in almost all
the examined samples. These findings make us envis-
age another application of HR-MAS NMR, in con-
junction with in vivo MRS—the detection of drugs or
the metabolic changes induced by them.
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